IndexIQ Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History
Bought
Maintained
Sold
IndexIQ Advisors's OPTR Position: Q4 2013 in Review
IndexIQ Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 6,185 shares — an estimated $78K sold.
IndexIQ Advisors first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $78K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.
- IndexIQ Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
- IndexIQ Advisors sold 6,185 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $78K.
- IndexIQ Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
- IndexIQ Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $78K in Q3 2013.
- 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.
Based on IndexIQ Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.